Scarica l'app Stockscreener
1.23
1.60%
-0.02
Pre-mercato:
1.25
0.02
+1.63%
Precedente Chiudi:
$1.25
Aprire:
$1.24
Volume 24 ore:
58,556
Relative Volume:
0.30
Capitalizzazione di mercato:
$51.51M
Reddito:
-
Utile/perdita netta:
$-11.24M
Rapporto P/E:
-1.6152
EPS:
-0.7615
Flusso di cassa netto:
$-4.79M
1 W Prestazione:
+4.24%
1M Prestazione:
-15.75%
6M Prestazione:
-16.89%
1 anno Prestazione:
+7.89%
Intervallo 1D:
$1.22
$1.28
Intervallo di 1 settimana:
$1.15
$1.28
Portata 52W:
$0.73
$2.45
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Nome
Mira Pharmaceuticals Inc
Settore
Industria
Telefono
813-369-5150
Indirizzo
1200 BRICKELL AVENUE, MIAMI
Compare MIRA vs LLY, JNJ, ABBV, AZN, NVS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.23 | 52.35M | 0 | -11.24M | -4.79M | -0.7615 |
|
LLY
Lilly Eli Co
|
1,020.56 | 977.37B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
244.99 | 586.40B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
228.72 | 411.55B | 61.16B | 4.20B | 19.68B | 2.3671 |
|
AZN
Astrazeneca Plc
|
208.67 | 324.75B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
165.38 | 317.08B | 54.72B | 14.02B | 15.32B | 7.1855 |
Mira Pharmaceuticals Inc Borsa (MIRA) Ultime notizie
What is MIRA Pharmaceuticals Inc. s revenue forecastEarnings Overview Report & Daily Price Action Insights - mfd.ru
MIRA Pharmaceuticals Inc. (MIRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What are MIRA Pharmaceuticals Inc.’s recent SEC filings showingPortfolio Value Summary & High Conviction Buy Zone Alerts - mfd.ru
How does MIRA Pharmaceuticals Inc. compare to its peersJuly 2025 PreEarnings & Daily Technical Stock Forecast Reports - mfd.ru
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
MIRA Pharmaceuticals (NASDAQ:MIRA) Shares Down 6.6%Time to Sell? - MarketBeat
MIRA Pharmaceuticals (NASDAQ:MIRA) Stock Price Down 6.6%Time to Sell? - MarketBeat
Bear Alert: How is GIGGW managing supply chain issues2025 Big Picture & Long Hold Capital Preservation Plans - baoquankhu1.vn
MIRA Pharmaceuticals initiates final dosing in phase 1 trial of Ketamir-2 - Investing.com Nigeria
MIRA Pharmaceuticals initiates final dosing in phase 1 trial of Ketamir-2 By Investing.com - Investing.com South Africa
MIRA Pharmaceuticals Initiates Final Cohort of Ketamir-2 Phase 1 Clinical Study as Company Prepares for Phase 2a Study - Rutland Herald
Cancer nerve pain has no approved drugs. Oral trial nears first-phase finish - Stock Titan
MIRA Pharmaceuticals Advances Ketamir-2 Phase 1 to Final Cohort - TipRanks
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog - Pensacola News Journal
Value Recap: What is the Moat Score of MIRA Pharmaceuticals IncWeekly Trade Summary & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Fundamentals Check: What is AVGOs revenue forecastMarket Sentiment Summary & Reliable Price Breakout Signals - baoquankhu1.vn
Can MIRA Pharmaceuticals Inc. stock deliver consistent earnings growthGlobal Markets & Safe Entry Zone Identification - bollywoodhelpline.com
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Sees Significant Growth in Short Interest - Defense World
Nasdaq Moves: Is DiaMedica Therapeutics Inc a cyclical or defensive stockMarket Performance Summary & Expert Verified Movement Alerts - baoquankhu1.vn
Aug Big Picture: How does MIRA Pharmaceuticals Inc compare to its peersGap Down & Detailed Earnings Play Strategies - baoquankhu1.vn
Will MIRA Pharmaceuticals Inc. stock maintain dividend yieldWide Width Options & HOKA model picks for your routine - Улправда
Trendlines Suggest Garment Mantra Lifestyle Limited May Bottom Out Soon - Bollywood Helpline
2026 world cup usa national team qualification midfield leaders build up play winner prediction guideJuly 2025 Volume & Low Volatility Stock Recommendations - Улправда
2026 world cup mexico qualification playmakers low block knockout prediction analysis - Улправда
2026 world cup canada qualification match preview insightsIndex Update & Fast Entry and Exit Trade Plans - Улправда
Quarterly Risk: Will MIRA Pharmaceuticals Inc stock gain from strong economyJobs Report & Real-Time Buy Signal Alerts - Bộ Nội Vụ
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Update - MarketBeat
Resistance Break Could Fuel Unichem Laboratories Limited RallyEarnings Beat Highlights & Maximize Gains Professionally - Bollywood Helpline
Mira Pharmaceuticals approves CEO incentive awards including SKNY acquisition bonus By Investing.com - Investing.com South Africa
Mira Pharmaceuticals approves CEO incentive awards including SKNY acquisition bonus - Investing.com
Will MIRA Pharmaceuticals Inc. stock gain from strong economyJuly 2025 Recap & Fast Moving Stock Trade Plans - Bölüm Sonu Canavarı
Is MIRA Pharmaceuticals Inc. stock a safe investment in uncertain markets2025 Price Targets & Fast Entry Momentum Trade Alerts - Улправда
MIRA Pharmaceuticals (MIRA) details 2025 CEO bonuses and equity awards - Stock Titan
Can MIRA Pharmaceuticals Inc. stock beat analyst upgradesOptions Play & Weekly Setup with ROI Potential - Улправда
Is MIRA Pharmaceuticals Inc. stock attractive for growth ETFsMarket Performance Recap & Technical Pattern Alert System - Улправда
MIRA Pharmaceuticals (NASDAQ:MIRA) Trading Up 2.1% – Here’s What Happened - Defense World
MIRA Pharmaceuticals (NASDAQ:MIRA) Trading Up 2.1%Here's What Happened - MarketBeat
MIRA Pharmaceuticals expands stock offering by $15M - MSN
Mira Pharmaceuticals increases at-the-market offering by $15.2 million - Investing.com Canada
MIRA Pharmaceuticals Expands Stock Offering by $15M - TipRanks
MIRA Pharmaceuticals Increases Stock Offering Limit - TradingView — Track All Markets
Mira Pharmaceuticals (MIRA) Stock Analysis Report | Financials & Insights - Benzinga
How MIRA Pharmaceuticals Inc. stock performs in rising dollar environmentTrade Ideas & Verified Technical Signals - Newser
Why MIRA Pharmaceuticals Inc. stock is seen as undervaluedJuly 2025 Review & Daily Technical Forecast Reports - Newser
Is MIRA Pharmaceuticals Inc. stock attractive for passive investorsTrade Volume Summary & Fast Exit and Entry Trade Guides - Newser
Mira Pharmaceuticals Inc Azioni (MIRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.00%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):